Search

everythinglearnresearchcommunity

for

Search:↓

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Early hair loss links to metabolic issues in young Indian men.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

Some birth control pills can cause hair loss, and switching to ones with less androgen should help.

Higher androgen levels are linked to more severe hair growth in hirsute women.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Melatonin improved mental health and metabolism in women with PCOS.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Obese and lean women with PCOS have different symptoms and need different treatments.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Long-term finasteride use doesn't change bone density or metabolism.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.